Fousek, Kristen http://orcid.org/0000-0002-2307-5000
Watanabe, Junji
Joseph, Sujith K.
George, Ann
An, Xingyue
Byrd, Tiara T.
Morris, Jessica S.
Luong, Annie
MartÃnez-Paniagua, Melisa A.
Sanber, Khaled
Navai, Shoba A. http://orcid.org/0000-0003-1220-2788
Gad, Ahmed Z. http://orcid.org/0000-0002-6149-3414
Salsman, Vita S.
Mathew, Pretty R.
Kim, Hye Na
Wagner, Dimitrios L. http://orcid.org/0000-0002-2189-3579
Brunetti, Lorenzo
Jang, Albert
Baker, Matthew L.
Varadarajan, Navin
Hegde, Meenakshi
Kim, Yong-Mi
Heisterkamp, Nora
Abdel-Azim, Hisham
Ahmed, Nabil
Funding for this research was provided by:
Kure It Cancer Research Foundation, Rivals united Kure Grant 2017
EIF | Stand Up To Cancer (SU2C-AACR-DT1113)
Article History
Received: 22 October 2019
Revised: 23 February 2020
Accepted: 28 February 2020
First Online: 24 March 2020
Compliance with ethical standards
:
: KF, TTB, MH, YK, NH, HA, and NA have patent applications in the field of gene modified T-cell therapy for cancer. NV is founder and CSO of CellChorus.